Argon Intelligence - CI Solution

Argon Intelligence - CI Solution

Published

10/7/2025

Author

Samy Danesh

Rebuilding Competitive Intelligence with AI at its core

Argon_CI_v4 from Cyrus Jia on Vimeo

We are excited to launch Argon Intelligence - a mixture of AI Agents specialized in completing end-to-end CI workflows.

Argon Intelligence orchestrates thousands of LLMs to help automate the drudgery of CI. From tracking updates, to drafting alerts and implications, to automatically maintaining indication landscapes, Agents can do it all.

Our vision for the future is one in which AI Agents elevate people to higher level, strategic roles. And The future of the CI function is one of deep strategic importance.

Why Competitive Intelligence Is Broken Today

In biopharma, the pace of change has never been faster. A single trial update, regulatory notice, or congress presentation can shift the landscape overnight. Competitive Intelligence (CI) teams are tasked with tracking hundreds of moving parts - new clinical data, mechanism-of-action announcements, commercial strategies, conference chatter, and shifting regulatory signals.

Tracking these changes is one thing, understanding what these shifts mean for a development program is another. Teams today typically spend dozens of hours trying to understand new clinical data or regulatory shifts.

Take the example of a clinical trial presenting new safety and efficacy data. Analysts spend dozens of hours contextualizing the data itself - which endpoints were measured, the patient populations, safety signals from previous trials, and more. The data is then compared to existing standards of care or company assets to further contextualize the trial data. Typical outputs include clinical data tables like the example below from the recent read out from the Phase 3 ICONIC-TOTALa study investigating Icotrokinra (JNJ-2113) by J&J.

This single example takes dozens of hours to complete. Now imagine doing this across large portfolios of drugs & assets.

AI is poised to change that. Done right, AI doesn’t replace CI professionals - it amplifies them. It takes the manual, repetitive work off their plates and transforms CI into a proactive, real-time strategic partner.

Competitive Intelligence: From Reactive to Proactive

The core shift is simple: AI Agents enable CI to move from a reporting function to a forward-looking strategic function.

AI systems are well suited to handling large amounts of incoming data and reasoning on top of the data to understand updates that may be relevant to your asset.

The Four Stages of AI-Enabled CI

1. Capture: Automating the Firehose

The pain today: CI teams spend countless hours gathering data. Sources are fragmented - ClinicalTrials.gov, PubMed, ASCO/EHA abstracts, investor transcripts, medical literature, SEC filings, and many more. Coverage is patchy and updates are easily missed. At best, teams use RSS feeds or Google Alerts to capture new data and keyword filters to parse through all the text.

What AI changes: Retrieval pipelines powered by AI can continuously monitor these sources, normalize the formats, and push updates directly into a central workspace. Rather than keyword based analysis, AI considers all of the text and applies reasoning to determine if something is relevant or not. As a result, teams get true updates rather than just appearance of keywords - assessing the full context of the new information rather than keyword mentions.

Example: Instead of an analyst refreshing ClinicalTrials.gov every Friday, or sifting through keyword update to determine relevance, an AI agent can act as a thorough, highly accurate thought-partner to sift through thousands of data point daily and flag relevant updates.

2. Synthesize: From Documents to Insights

The pain today: Once data is gathered, it sits in silos. Analysts spend days stitching together trial summaries, patient populations, endpoints, and readouts. Often, multiple documents point to the same update, so teams have to track multiple documents to get a 360 view of an update. Hours are spent contextualizing an update with additional research and drafting thoughtful implication sections of what a competitor update means for an indication space.

What AI changes: AI can generate structured comparative tables in minutes, pulling trial arms, MOAs, endpoints, geographies, and results into a clean, digestible format. Agents can relate documents about a single topic and generate an updated synthesis that captures the full view of the update. Teams can review updates, overviews, & implications drafts, make tweaks, and distribute insights across the broader organization.

Example: A mCRPC clinical trial publishes efficacy & safety data in an ASCO abstract. Argon captures the abstract and corresponding press releases and news into a single update. The Agent drafts an update synthesis across all documents and news. The Agent then researches how this data could change the mCRPC landscape, produces a comparative clinical trial table - trials, sponsors, patient population details, endpoints, and resulting data - with citations to the source.

3. Building a CI Library: A Single Source of Truth (SSOT)

The pain today: Insights are stored across emails, 20-slide decks, and dispersed documents across company internal file systems. Most team members don’t have time to comb through dense PDFs & slide decks, and the history of CI outputs is lost in large data repositories. Often, by the time information trickles out, it’s outdated and the history of insights is lost.

What AI changes: Over time, all updates, insights, and outputs are stored in a single, searchable, centralized repository. Teams can access this repository to search for historical events and generate reports. AI can package insights into formats tailored to different stakeholders:

Example: Every month, CI teams access the CI Library and generate a monthly report. Agents sort through high priority updates and generate a final monthly report highlighting the biggest landscape shifts, aligning all of your teams on the latest strategic implications that matter most.

4. Integrate: Pull in Data Sources Spanning Claims to Internal data

The pain today: Secondary data is a key foundation of CI, but teams also have internal and 3rd party data sources they leverage including claims data, 3rd party sources for drug revenue, and much more. These sources are all siloed with different reporting mechanisms, exasperating an already fragmented workflow.

What AI changes: Agent are capable of both understanding and working with a wide range of sources. A multi-agent platform can run code on claims data, synthesize revenue numbers, and effectively work with a number of data sources. The generalized capabilities power a single platform to handle all data and corresponding workflows.

Example: Argon is able to track an entire landscape across publications, SEC filings, press releases and insurance claims. The platform brings together multiple Agents spanning different data sources for a comprehensive and de-fragmented landscape view.

The Future of CI as a Core Strategic Pillar

CI is often viewed as a rear-view mirror function. Teams document what competitors did, but struggle to advise on what comes next. Most of the manpower and time is spent on reporting functions to deal with the overload and deluge of incoming data.

In 2026 and onwards, the most effective biopharma CI teams won’t just use AI - they’ll be built around it.

With much of tracking and reporting automated, people will be elevated to deeper strategic and advisory roles. Spending less time wrangling data and more time deeply contemplating what changed in the landscape mean for asset strategy.